Andrew Leach joins EMBL’s European Bioinformatics Institute

Company
EMBL's European Bioinformatics Institute
Appointee name
Andrew Leach
Country

United Kingdom

Andrew Leach, formerly global head of biomolecular sciences at GlaxoSmithKline Plc, is to join the European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI) as head of chemistry services. Dr Leach, who holds a PhD in chemistry from Oxford University, spent more than two decades at GSK during which time he also was a trustee of the Cambridge Crystallographic Data Centre and editor of the Journal of Computer-Aided Molecular Design. He will take up his new post on 1 September and be based at the Wellcome Genome Campus in Hinxton, Cambridge, UK.

The appointment was announced on 10 March 2016.

Copyright 2016 Evernow Publishing Ltd